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Abstract
Background: Mutations in the gene encoding filamin A (FLNA) lead to diseases with high phenotypic diversity
including periventricular nodular heterotopia, skeletal dysplasia, otopalatodigital spectrum disorders, cardiovascular
abnormalities, and coagulopathy. FLNA mutations were recently found to be associated with lung disease. In this
study, we report a novel FLNA gene associated with significant lung disease and unique angiogenesis.
Case presentation: Here, we describe a 1-year-old Saudi female child with respiratory distress at birth. The
child then had recurrent lower respiratory tract infections, bilateral lung emphysema with basal atelectasis,
bronchospasm, pulmonary artery hypertension, and oxygen and mechanical ventilation dependency. Molecular
testing showed a new pathogenic variant of one copy of c.3153dupC in exon 21 in the FLNA gene.
Conclusions: Our data support previous reports in the literature that associate FLNA gene mutation and lung
disease.
Keywords: FLNA, Lung disease, Angiogenesis, Pediatrics
Background
Filamin A is a 280-kD protein that crosslinks actin fila-
ments into orthogonal networks in cortical cytoplasm
and participates in the anchoring of membrane proteins
for the actin cytoskeleton. Remodeling of the cytoskel-
eton is central to the modulation of cell shape and mi-
gration. Filamin A, encoded by the FLNA gene, is a
widely expressed protein that regulates reorganization of
the actin cytoskeleton by interacting with integrins, trans-
membrane receptor complexes, and second messengers,
thus mutations in the gene encoding filamin A (FLNA)
lead to diseases with high phenotypic diversity including
the following: periventricular nodular heterotopia (PNH),
skeletal dysplasia, otopalatodigital spectrum disorders
such as Melnick-Needles syndrome and frontometaphy-
seal dysplasia [1–5], cardiovascular abnormalities that
include patent ductus arteriosus (PDA), valvular disease,
aortic root dilatation and aneurysms, Ehlers-Danlos
syndrome-like phenotype [6–8], and coagulopathy with
thrombocytopenia [9]. Recently, Masurel-Paulet et al. [1],
de Wit and colleagues [10], and Lord et al. [11] reported
associations between pulmonary diseases in both sexes
with substantial heterogeneity in manifestations and le-
thality. Here, we report the case of a female child with a
novel FLNA gene mutation who developed significant
lung disease and unique angiogenesis.
Case presentation
Our patient is a 1-year-old Saudi female child who was
referred from another hospital after PDA ligation, left in-
guinal hernia repair, accidental fracture of her right ulna
and radius, and prolonged mechanical ventilation for
severe respiratory syncytial virus infection complicated
by acute respiratory distress syndrome. The patient was
sent to our hospital for further evaluation due to on-
going respiratory distress and hypoxemia. Our patient
was the third child of nonconsanguineous Saudi parents
and was born via cesarean section at 36 weeks gestation
due to fetal distress. The child was admitted to the neo-
natal intensive care unit for 5 days because of respiratory
distress and was ventilated for 36 hours. The mother has
epilepsy and the father has been diagnosed with Behcet's
disease. Since the age of 2 months, the child had mul-
tiple lengthy admissions in different hospitals (for 1 to 3
* Correspondence: malbalawi@hotmail.com
King Fahad Medical City, P.O. Box 59046, Riyadh 11525, Kingdom of Saudi
Arabia
© 2016 Eltahir et al. Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Eltahir et al. Journal of Medical Case Reports  (2016) 10:97 
DOI 10.1186/s13256-016-0871-1
months at a time) for recurrent cyanotic events, respira-
tory distress, frequent choking with feeding, and signifi-
cant vomiting. The child had accumulated the following
diagnoses: severe gastroesophageal reflux disease (GERD),
failure to thrive requiring prolonged nasogastric tube feed-
ing, patent ductus arteriosus, pulmonary hypertension, an-
oxic convulsions, chronic lung disease with prolonged
oxygen dependency, reversible bronchospasm, left exter-
nal iliac vein thrombosis, and developmental delay. She
had two prior prolonged stays at our institution.
The first admission was due to rhinovirus infection
and clinically diagnosed recurrent aspiration secondary
to aberrant right subclavian artery (dysphagia lusoria)
with prolonged oxygen therapy. The second admission
was for respiratory failure that required prolonged intub-
ation including high-frequency oscillatory ventilation
complicated by recurrent lung atelectasis and right lung
pneumothorax. She failed multiple trials of extubation
and unfortunately died of cardiac arrest due to sepsis
while receiving maximal supportive therapy. An initial
physical examination during the first admission revealed
a baby girl in poor health with the following clinical
values: moderate respiratory distress and a respiratory
rate of 70/min, heart rate of 144/min, blood pressure of
101/47 with saturation of 95% on 1.5 L/min, body
weight of 5.9 kg (below the third percentile), and height
of 69 cm (at the tenth percentile).The child had dimin-
ished breath sounds bilaterally with a prolonged expira-
tory phase, wheezing, and scattered crackles posteriorly,
mild hypotonia, and significant hyperlaxity. Investiga-
tions showed normal sweat chloride level, and immune
function testing was normal. A chest X-ray (Fig. 1)
showed multiple subsegmental atelectasis and areas of
air trapping. Computed tomography and angiography of
her chest (Fig. 2) revealed bilateral lower lobe airspace
disease, hyperinflation of the right middle lobe and left
upper lobe including the lingual, and an enlarged main
pulmonary artery. The sagittal view (Fig. 3) showed a
right aberrant subclavian artery causing posterior com-
pression to the esophagus at the level of the T4 vertebra
and minimal compression in the posterior trachea. An
echocardiogram showed no residual PDA or significant
evidence of pulmonary hypertension. Barium adminis-
tration (Fig. 4) showed external compression along the
posterior wall of the proximal third of the esophagus,
which was causing significant narrowing of the esopha-
geal lumen. The pH probe showed no significant GERD.
Upper gastrointestinal endoscopy showed there was a
narrowed and compressed area located 18 cm into the
esophagus at T4, and was identified with marked pulsa-
tion. The flexible bronchoscopy showed complete ring
and narrowing of the lower third of the trachea. A lung
biopsy (Fig. 5) showed alveolated lung parenchyma with
alveolar simplification, in which alveoli do not show age-
appropriate normal architecture, compared with the
normal alveolar architecture (Fig. 6). There was no mag-
netic resonance imaging (MRI) of the brain because our
patient's condition did not allow it.
Gene analysis
Molecular testing for FLNA-related disorders in our pa-
tient showed a new pathogenic variant of one copy of
c.3153dupC in exon 21 in the FLNA gene. This variant
has not been reported in individuals with FLNA-related
disorders but is expected to cause disease.
Fig. 1 Chest X-ray anteroposterior view shows multiple subsegmental
atelectasis, areas of air trapping and osteopenia
Fig. 2 Computed tomography angiography axial view below
bifurcation of carina shows basal lung atelectasis, lung hyperinflation,
and enlarged main pulmonary artery
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Discussion
In this case report, we describe another confirmatory
mutation in the gene encoding filamin A (FLNA) in a fe-
male child with lung disease. Our patient was a female
child who was confirmed to have a pathogenic variant of
the FLNA gene c.3153dupC. This mutation has not been
reported in individuals with FLNA-related disorders but
is expected to cause disease. Similar to other reported
cases, our child also manifested clinical symptoms at an
early age [10, 11]. She had respiratory distress at birth
and then had recurrent lower respiratory tract infections/
bronchiolitis, bilateral lung emphysema with basal atel-
ectasis, bronchospasm, pulmonary artery hypertension,
and long oxygen and mechanical ventilatory depend-
ency after 2 months of age. A lung biopsy showed
alveolated lung parenchyma with alveolar simplifica-
tion similar to the finding by Lord et al. [11]. This
child also manifested associated clinical features re-
ported with other filamin gene mutations including pa-
tent ductus arteriosis (PDA), hypotonia, joint laxity,
and developmental delay [10]. These clinical and
histological features are similar to cases reported with
the pulmonary phenotype of FLNA (Table 1). How-
ever, an unusual clinical manifestation in our case is
severe reflux that caused recurrent aspiration symp-
toms and dysphagia lusoria (secondary to aberrant
right subclavian artery that caused significant esopha-
geal compression). This abnormal angiogenesis has
been reported only in FLNA-null mice, which have
Fig. 3 Computed tomography angiography sagittal view shows
right aberrant subclavian artery posterior compression to the
esophagus at level of T4 vertebra and minimal compression in the
posterior trachea
Fig. 4 Barium meal shows external compression noted along
posterior wall of proximal third of the thoracic esophagus causing
significant narrowing of esophageal lumen
Fig. 5 Alveolated lung parenchyma (black arrows) with alveolar
simplification. Small yellow arrow: from the microscope that is
probably not relevant
Fig. 6 Normal alveolar septation
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Table 1 Features of reported cases of filamin A mutation
Masurel-Paulet et al. [1] de Wit et al. [10] Lord et al. [11] This case
Genetic mutation Mosaic nonsense filamin A mutation
(c.994delG.P.K331X)
Missense filamin A mutation
(c.220G>P.G74R )
Truncating filamin A mutation
(c.5683G>T,p.G1895*)
Pathogenic variant (c.3153dupC) in
exon 21 filamin A gene
Sex Male Female Female Female
Birth Term with uncomplicated perinatal
course
Term with uncomplicated perinatal
course
Premature at 30 weeks mild
respiratory distress resolved after
48 hours
Premature at 36 weeks with respiratory
distress, needed ventilation for first
36 hours




infections, asthma, prolonged oxygen
dependence, lung atelectasis and lung
cysts, tracheobronchomalacia, pulmonary
arterial hypertension
Dyspnea, recurrent respiratory infections,
prolonged oxygen dependence until
1 year and 7 months of age. Emphysema




oxygen dependence until 22
months of age bilateral pulmonary
atelectasis and cysts.
Tracheobronchomalacia
Recurrent cyanotic events, respiratory
distress, episodes of choking and vomiting,
with associated bronchospasm pulmonary
arterial hypertension, prolonged oxygen
and ventilator dependence until death at
15 months of age, bilateral pulmonary
emphysema and basal atelectasis tracheal
stenosis
Chest X-ray Bilateral subsegmental atelectasis with
hyperlucent areas in both mid zones
Cystic pulmonary lesions alternating
with heterogeneous areas of
atelectasis
Multiple subsegmental atelectasis and
areas of air trapping
Chest CTscan Widespread peribronchial thickening,
subsegmental collapse, fluid within
oblique fissure, eventration of the left
hemidiaphragm
Severe lobar emphysema of right middle l
obe with displacement of medistinal
structures to left and compression of left
upper lobe
Patchy ground-glass appearance
with area of hyperinflation and
cystic pulmonary lesions alternating
with heterogeneous areas of
atelectasis and thickening of
interlobar septa
Bilateral lower lobe airspace diseases,
hyperinflation of both upper lobes,
enlarged main pulmonary artery, right
aberrant subclavian artery, compressing
esophagus and trachea
Surgery Subtotal upper lobectomy at age of
8 months for lobar emphysema.
Lobectomy of right middle lobe for lobar
emphysema
Lung histology results Panpulmonary emphysema with global
absence of bronchial cartilage and
hypertensive pulmonary vascular disease
Lung emphysema without inflammation Mild to moderate chronic lung
disease with associated alveolar
simplification and pulmonary
hypertension




Periventricular nodular heterotopia with
left cerebellar hemisphere hypoplasia and
cisterna magna, truncal hypotonia, PDA,
aortic root dilatation, bifid right urinary
drainage system supraumbilical hernia,
macrothrombocytes
Periventricular nodular heterotopia, with
an enlarged retrocerebellar cyst, secundum
atrial septal defect and coarctation of the
aorta, hypotonia, severe hyperlaxity
Periventricular nodular heterotopia,
secundum atrial septal defect, mild
axial hypotonia
Suspected periventricular nodular heterotopia,
PDA, angiogenesis causing dysphagia lusoria,
hypotonia and joint laxity
Outcomes Follow-up to 6 years Follow-up to 3 years Follow-up to 22 months Death at 15 months












vascular endothelial cells that show defective cell–cell
contacts and adherens junctions. The result is abnormal
angiogenesis with disorganized blood vessels and aberrant
branching [7, 12]. There are other possible pulmonary
phenotypes of FLNA gene mutation suggested due to its
role in T cell activation, interleukin production [13], in-
flammatory signaling [14], and interaction with the cystic
fibrosis transmembrane conductance regulator [15]. There
has been no specific sensitivity to infections observed in
FLNA patients [10]. However, our patient was noted to
have severe prolonged courses of viral or bacterial infec-
tions. The pathogenic variant of FLNA gene mutation in
our reported case is not confirmed to have association
with periventricular nodular heterotopias (PNH), and our
patient was too ill to complete brain MRI. The patient’s
mother has epilepsy beginning in the third decade of life.
The patient’s father has Behcet’s disease, which is highly
consistent with other reports of PNH [8, 16, 17].
Conclusions
In conclusion, we support the three previous reports in
the literature, stating that there is an association be-
tween FLNA gene mutation and lung disease. The lung
disease is a lethal condition likely manifested by early
onset of pneumonia and recurrent bronchiolitis, subse-
quent asthma, pulmonary hypertension, and long-term
oxygen dependency with underlying lung emphysema or
lung cysts. FLNA mutation is also associated with airway
anomalies such as tracheal stenosis (as in our patient) or
tracheobronchomalacia. In addition, there are other di-
verse associated clinical manifestations.
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